Recent studies revealed that Floratek’s new chemical entities exhibited picomolar activity in cancer cells

After meticulous SAR refinement through multiple rounds of chemical modifications the new generation of compounds demonstrated remarkable low picomolar activity towards different cancer cells in vitro. Their potent cytotoxic activity surpasses the cytotoxicity observed in standard-of-care drugs tested within the same cancer model.